|
|
Volumn 61, Issue 4, 2002, Pages 1545-1547
|
|
ACE inhibitors and AT1 receptor antagonists: Is two better than one?
|
|
Author keywords
Angiotensin II receptor antagonists; Angiotensin converting enzyme inhibitors; Chronic renal disease; Nitric oxide; Renal hemodynamics
|
|
Indexed keywords
ANGIOTENSIN 2 RECEPTOR ANTAGONIST;
CANDESARTAN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ENALAPRIL;
EPROSARTAN;
IRBESARTAN;
LISINOPRIL;
N(G) NITROARGININE METHYL ESTER;
NITRIC OXIDE SYNTHASE;
ANGIOTENSIN 1 RECEPTOR;
ANGIOTENSIN RECEPTOR;
BLOOD PRESSURE REGULATION;
CHRONIC KIDNEY FAILURE;
CLINICAL TRIAL;
DRUG POTENTIATION;
EDITORIAL;
ESSENTIAL HYPERTENSION;
GLOMERULUS FILTRATION RATE;
HEART PROTECTION;
HUMAN;
KIDNEY BLOOD FLOW;
KIDNEY VASCULAR RESISTANCE;
MEMBRANOUS GLOMERULONEPHRITIS;
NONHUMAN;
PRIORITY JOURNAL;
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;
TREATMENT OUTCOME;
ANIMAL;
CHRONIC DISEASE;
DISEASE COURSE;
DRUG ANTAGONISM;
DRUG COMBINATION;
KIDNEY DISEASE;
NOTE;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
ANIMALS;
CHRONIC DISEASE;
DISEASE PROGRESSION;
DRUG THERAPY, COMBINATION;
HUMANS;
KIDNEY DISEASES;
KIDNEY FAILURE, CHRONIC;
RECEPTOR, ANGIOTENSIN, TYPE 1;
RECEPTORS, ANGIOTENSIN;
|
|
EID: 0036229478
PISSN: 00852538
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1523-1755.2002.00261.x Document Type: Editorial |
|
Times cited : (11)
|
|
References (10)
|
